Patent details

92768 Product Name: Secukinumab

Basic Information

Publication number:
92768
Type:
SPC
SPC Type:
Medizin-
Basic Patent Number:
EP057702862
Legal Status:
Inaktiv
Application number:
92768
First applicant's nationality:
Procedural language:
Französisch

Paediatric Extension

SPC Extension Filing Date:
17/06/2022
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Erteilt
SPC Extension Grant Date:
21/10/2024
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/14/980 - Cosentyx - Secukinumab
Marketing Authorization Type:
Marketing Authorization Date:
19/01/2015
Marketing Authorization Status:
akzeptiert
Marketing Authorization Country:

Dates

Filing date:
10/07/2015
First Marketing Authorization date:
19/01/2015
Grant date:
03/11/2015
Activation date:
Publication date:
03/11/2015
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
19/01/2030
SPC Extension Expiration:
19/07/2030
Rejection date:
Withdrawal date:

Owner

From:
10/07/2015
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Schweiz (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
10/07/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxemburg (LU)
To:

Inventor

1

Name:
RONDEAU Jean-Michel
Address:
Frankreich (FR)

2

Name:
VAN DEN BERG Wim
Address:
Niederlande (NL)

3

Name:
DI PADOVA Franco, E.
Address:
Schweiz (CH)

4

Name:
JESCHKE Margit
Address:
Schweiz (CH)

5

Name:
GRAM Hermann
Address:
Deutschland (DE)

6

Name:
HOFSTETTER Hans
Address:
Schweiz (CH)

Publication

Bulletin

1

Bulletin Heading:
SPCX1
Bulletin edition number:
2022/08
Publication date:
01/07/2022
Description:
Sektion G : Ergänzende Schutzzertifikate – Anträge auf Verlängerungen – I1E Veröffentlichung

2

Bulletin Heading:
SPCX2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Sektion H : Erteilte Verlängerungen für ergänzende Schutzzertifikate – I2E Veröffentlichung

Annual Fees

Annual Fee Due Date:
31/08/2025
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
17/06/2022 Antragsformular 3
17/06/2022 Pädiatrisches Prüfkonzept 1
17/06/2022 Genehmigung für das Inverkehrbringen 3
17/06/2022 Zusammenfassung der Merkmale des Erzeugnisses 204
17/06/2022 Allgemeines Dokument 2
17/06/2022 Ausgehende Korrespondenz 1
17/06/2022 Veröffentlichung 1
21/10/2024 Veröffentlichung 1
21/10/2024 Zertifikat 1
17/06/2022 FNET_DC_FRONTPAGE 1
22/10/2024 Ausgehende Korrespondenz 1